CDC. 2011a. CDC Drug Service [online]. Available: http://www.cdc.gov/laboratory/drugservice/index.html [accessed Apr. 22, 2011].
CDC. 2011b. Fatal laboratory-acquired infection with an attenuated Yersinia pestis strain—Chicago, Illinois, 2009. Morbidity and Mortality Weekly Report 60(07):201-205.
CDC/APHIS (Centers for Disease Control and Prevention and Animal and Plant Health Inspection Service). 2008. Select Agents and Toxins: Theft, Loss and Release Information Document. 7 CFR Part 331.19, 9 CFR Part 121.19, 42 CFR Part 73.19. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Division of Select Agents and Toxins, Atlanta, GA, and U.S. Department of Agriculture, Animal and Plant Health Inspection Service, Agriculture Select Agent Program, Riverdale, MD. Jan. 18, 2008 [online]. Available: http://www.selectagents.gov/resources/CDC-APHIS_Theft_Loss_Release_Information_Document.pdf [accessed Mar. 8, 2011].
CDC/NIH (Centers for Disease Control and Prevention and National Institutes of Health). 2009. Biosafety in Microbiological and Biomedical Laboratories, 5th Ed., L.C. Chosewood, and D.E. Wilson, eds. HHS Publication No. (CDC) 21-1112. Washington, DC: U.S. Government Printing Office [online]. Available: http://www.cdc.gov/biosafety/publications/bmbl5/BMBL.pdf [accessed Mar. 8, 2011].
Christova, I. 2009. Bulgarian vaccine against CCHFV. Presentation at Arbo-Zoonet Symposium: Interventions against WNV, RVFV and CCHFV: Where are we? Nov. 19-20, 2009, Istambul, Turkey [online]. Available: http://www.arbo-zoo.net/_data/1-Iva_Christova_istanbul09.pdf [accessed Mar. 11, 2011].
Covert, N.M. 2000. Cutting Edge: A History of Fort Detrick, Maryland, 4th Ed. Fort Detrick Public Affairs Office [online]. Available: http://www.detrick.army.mil/cutting_edge/index.cfm [accessed Mar. 8, 2011].
Crumrine, M. 2010. Special Immunizations Program: NIAID perspective. Presentation at the First Meeting of the Committee on Special Immunizations Program for Laboratory Personnel Engaged in Research on Countermeasures for Select Agents, Mar. 4, 2010, Washington, DC.
DOD (U.S. Department of Defense). 2001. Report on Biological Warfare Defense Vaccine Research and Development Programs. U.S. Department of Defense, Washington DC. July 2001 [online]. Available: http://www.defense.gov/pubs/reportonbiologicalwarfaredefensevaccineRDPrgrasJuly2001.pdf [accessed Mar. 10, 2011].
DOD. 2008. Roles and Responsibilities Associated with the Chemical and Biological Defense (CBD) Program (CBDP). DOD Directive No. 5160.05E, Oct. 9 2008 [online]. Available: http://www.dtic.mil/whs/directives/corres/pdf/516005p.pdf [accessed Mar. 8, 2011].
DOD. 2009. Protocol for Participation in the Special Immunization Program, FY05-15, Amendment No. 4. U.S. Department of Defense, Office of the Human Use Committee. HUC Submission Dec. 10, 2009.
DOD. 2010. Quadrennial Defense Reviews. U.S. Department of Defense [online]. Available: http://www.defense.gov/qdr/ [accessed Mar. 8, 2011].
Drew, S.W. 2007. Platforms for vaccine manufacturing. Pp. 37-54 in WTEC Panel Report on International Assessment of Research and Development in Rapid Vaccine Manufacturing. World Technology Evaluation Center, Inc., Baltimore, MD [online]. Available: http://www.wtec.org/vaccmfg/RapidVaccMfg-finalreport.pdf [accessed Mar. 8, 2011].
DVC LLC (DynPort Vaccine Company LLC). 2011. DynPort Vaccine Company LLC: Case Studies [online]. Available: http://www.csc.com/dvc [accessed Mar. 8, 2011].
Eitzen, E. 2004. Special Immunization Program (SIP) Subgroup—Weapons of Mass Destruction Medical Countermeasures (WMDMCS): Final Policy Recommendations to U.S. Homeland Security Council Policy Coordinating Committee, December 2004.